Health Consequences of Wintering in the French Southern and Antarctic Territories

NCT ID: NCT04768621

Last Updated: 2023-09-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

232 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-04-20

Study Completion Date

2021-06-19

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Polar stays expose people to extreme climate, isolation and confinement. The combination of these factors induces psychological disorders, sleep disorders, immune and endocrine disturbances, and deficiencies. In the TAAF, (French Southern and Antarctic Lands) two types of population coexist: winter residents, exposed to these stressors over long periods, and country people, who benefit from milder conditions and only make short stays. In this context, the investigators have decided to set up this cohort study with the objective of comparing the state of health of the winterers of the TAAF from 2012 to 2017 with that of the country people of the same period, before their stay, during and the year following their return.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Participants will answer to a questionnaire. This questionnaire will determinate participants health about following areas : psychological disorders, sleep disorders, immune and endocrine disturbances, and any deficiencies.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Environmental Exposure Winter Depression Endocrine System Diseases Sleep Disorder Immunologic Activity Alteration

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SINGLE_GROUP

Questionnaire
Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Winter residents of Southern and Antartic French Lands,

people exposed to stressors over long periods including winter

Group Type EXPERIMENTAL

Questionary

Intervention Type OTHER

Questions about patient health after wintering in Southern and Antarctic French Lands about social and demographics items, psychologic and psychiatric items, sleep disorders, immunological disorders,and endocrinologic disorders, sociological consequences of wintering

Country people going to Southern and Antartic French Lands

people going to Southern and Antarctic French Lands who benefit from milder conditions and only make short stays

Group Type ACTIVE_COMPARATOR

Questionary

Intervention Type OTHER

Questions about patient health after wintering in Southern and Antarctic French Lands about social and demographics items, psychologic and psychiatric items, sleep disorders, immunological disorders,and endocrinologic disorders, sociological consequences of wintering

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Questionary

Questions about patient health after wintering in Southern and Antarctic French Lands about social and demographics items, psychologic and psychiatric items, sleep disorders, immunological disorders,and endocrinologic disorders, sociological consequences of wintering

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

for the exposed group are:

* To have carried out one or more wintering in one of the districts of the TAAF, that means a stay of at least six consecutive months including winter;
* Have started their first wintering between 01jan2012 and 31dec2017;
* Know how to read and write French.

for the non-exposed group are:

* To have taken part in one or more summer campaigns between 01jan2012 and 31dec2017;
* Never have overwintered;
* Not having been refused wintering for health reasons or following psychological tests;
* Knowing how to read and write French.

Exclusion Criteria

* Persons under guardianship or guardianship, deceased persons, persons refusing to participate in the study
Minimum Eligible Age

18 Years

Maximum Eligible Age

99 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Hospitalier Universitaire de la Réunion

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Nicolas BOUSCAREN

Role: PRINCIPAL_INVESTIGATOR

CIC 1410

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHU de la Réunion

Saint-Denis, , Reunion

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Reunion

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2020/CHU/38

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Senior Health Clinic Study
NCT05634239 UNKNOWN NA
Active Ageing and Health
NCT03858114 COMPLETED NA